Fulcrum Therapeutics Inc (FULC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,999 | -70,819 | -53,099 | -34,137 | -18,452 |
| Depreciation Amortization | 603 | 2,379 | 1,646 | 1,092 | 539 |
| Accounts receivable | 1,999 | -2,531 | -592 | -755 | -325 |
| Accounts payable and accrued liabilities | 920 | 1,773 | 1,590 | 1,436 | 1,429 |
| Other Working Capital | -1,977 | 7,503 | 12,054 | -91 | 1,061 |
| Other Operating Activity | -772 | 8,040 | 4,572 | 3,130 | 544 |
| Operating Cash Flow | $-16,226 | $-53,655 | $-33,829 | $-29,325 | $-15,204 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,677 | -55,796 | -41,670 | -55,853 | -55,837 |
| PPE Investments | -262 | -1,342 | -870 | -777 | -567 |
| Investing Cash Flow | $12,415 | $-57,138 | $-42,540 | $-56,630 | $-56,404 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -13 | -50 | -37 | -24 | -12 |
| Common Stock Issued | 47,517 | 71,375 | 64,914 | 65,177 | 286 |
| Other Financing Activity | 0 | -193 | 0 | -193 | 0 |
| Financing Cash Flow | $47,504 | $71,132 | $64,877 | $64,960 | $274 |
| Beginning Cash Position | 58,144 | 97,805 | 97,805 | 97,805 | 97,805 |
| End Cash Position | 101,837 | 58,144 | 86,313 | 76,810 | 26,471 |
| Net Cash Flow | $43,693 | $-39,661 | $-11,492 | $-20,995 | $-71,334 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,226 | -53,655 | -33,829 | -29,325 | -15,204 |
| Capital Expenditure | -262 | -1,342 | -870 | -777 | -567 |
| Free Cash Flow | -16,488 | -54,997 | -34,699 | -30,102 | -15,771 |